Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX. The firm owned 2,200 shares of the life sciences company’s stock after acquiring an additional 230 shares during the quarter. Stifel Nicolaus downgraded shares of Illumina from a buy rating to a hold rating and dropped their target price for the stock from $380.00 to $280.00 in a research report on Tuesday, September 22nd. S hares of Illumina Inc.ILMN plunged more than 10% to reach $157.21 yesterday, after an analyst at investment bank Leerink Partners downgraded the company from Outperform to … The stock has a 50 day simple moving average of $335.16 and a 200 day simple moving average of $342.39. The Thesis . Cowen reiterated an outperform rating and issued a $335.00 price objective (up previously from $320.00) on shares of Illumina in a research note […] Illumina Inc. stock rises Wednesday, still underperforms market Jan. 13, 2021 at 8:55 p.m. Four analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and six have given a buy recommendation to the company. Illumina’s revenue for the quarter was down 12.5% compared to the same quarter last year. analyst downgrades Bank Bradesco BBD BBDO Credit Suisse Group CS Illumina ILMN SPOT Spotify Technology stock downgrades Post navigation Previous Post AbbVie (ABBV:NYS) and Kraft Heinz (KHC:NAS) Upgraded Next Post Royal Bank of Canada (RY:TSE) and Bank of Montreal (BMO:TSE) Are Undervalued Motley Fool. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the stock. Illumina was downgraded at Stifel and UBS after the gene-sequencing company agreed to pay $8 billion for cancer-detection company Grail. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. 09/22/2020 Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. Join … Roche dropped the hostile bid in April because of opposition from Illumina's shareholders. Mercer Global Advisors Inc. ADV boosted its holdings in shares of Illumina by 13.9% in the third quarter. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. Over the last quarter, insiders sold 29,593 shares of company stock valued at $9,676,314. NASDAQ:ILMN opened at $370.00 on Thursday. Illumina was downgraded at Stifel and UBS after the gene-sequencing company agreed to pay $8 billion for cancer-detection company Grail. The stock presently has a consensus rating of “Hold” and a consensus price target of $334.14. Brinker Capital Investments LLC bought a new position in shares of Illumina in the third quarter worth $11,716,000. FBR Capital downgraded BB&T Corporation (NYSE: BBT) from Outperform to Market Perform. Zacks Investment Research downgraded shares of Illumina from a buy rating to a hold rating in a … Illumina stock (ticker: ... Evercore ISI analyst Vijay Kumar downgraded Illumna to Underperform from In Line, writing that the results underline … JPMorgan Chase & Co. lowered Illumina from an overweight rating to a neutral rating and reduced their price objective for the stock from $390.00 to $280.00 in a research report on Monday, September 21st. Illumina (NASDAQ:ILMN) stock is on a tear. Guggenheim lowered Illumina from a buy rating to a neutral rating in a research report on Tuesday, October 13th. Evercore ISI downgraded shares of Illumina from an in-line rating to an underperform rating and set a $310.00 price objective on the stock. Illumina (ILMN) Downgrade. Other equities research analysts have also issued research reports about the company. JPMorgan Chase & Co. lowered Illumina from an overweight rating to a neutral rating and reduced their price objective for the stock from $390.00 to $280.00 in a research report on Monday, September 21st. Several other research analysts have also recently issued reports on the company. Illumina had a return on equity of 15.93% and a net margin of 19.70%. Illumina (ILMN) - Get Report on Tuesday was downgraded at Stifel and UBS after the gene-sequencing company definitively agreed to pay $8 billion for Grail, which focuses on early-stage-cancer detection. Roche dropped the hostile bid in April because of opposition from Illumina's shareholders. Posted by Marion Hillson on Jan 1st, 2021. Subscribe. ValuEngine downgraded shares of Illumina (NASDAQ:ILMN) from a buy rating to a hold rating in a report released on Friday, ValuEngine reports. Stifel Nicolaus’ target price points to […] Analyzing Illumina (NASDAQ:ILMN) stock? Scott & Selber Inc. boosted its position in shares of Illumina by 0.5% during the 3rd quarter. 07:52 AM ET. Shares of U.S. Xpress Enterprises, Inc. (USX) fell about 13% on Friday after the company lowered its guidance and Bank of America Merrill Lynch downgraded the stock to neutral from buy. Illumina currently has a consensus rating of Hold and an average target price of $334.14. Bank Bradesco (BBD:NYS) and Illumina (ILMN:NAS) Downgraded. Illumina (NASDAQ:ILMN) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Thursday, BidAskClub reports. ... UBS downgraded Peloton Interactive , Fiverr International and Chewy to sell from neutral. Illumina downgraded to neutral from buy at UBS MarketWatch. Illumina has a 12-month low of $196.78 and a 12-month high of $404.20. Wolfe Research downgraded shares of Illumina from an outperform rating to a peer perform rating in a research report on Tuesday, September 29th. Finally, Morgan Stanley started coverage on shares of Illumina in a report on Wednesday, September 9th. Illumina had a return on equity of 15.93% and a net margin of 19.70%. Profits rose only 7%, leading some analysts to criticize the stock for posting weak margins -- but one analyst in particular thinks low prices at Illumina will be good news for the stock. Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, … The shares were sold at an average price of $315.32, for a total value of $397,303.20. Van ECK Associates Corp boosted its holdings in shares of Illumina by 0.8% in the third quarter. Keith began writing for … S&P 500 3,798.91. Illumina (NASDAQ:ILMN) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina, Inc provides sequencing and array-based solutions for genetic and genomic analysis. See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Since Oct. 15 the shares are up 9.7 percent. Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter. Buckley Wealth Management LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 11.7% in the 4th quarter, Holdings Channel reports. Buckley Wealth Management LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 11.7% in the 4th quarter, Holdings Channel reports. Smithfield Trust Co. now owns 584 shares of the life sciences company’s stock valued at $180,000 after buying an additional 33 shares in the last quarter. The investment banking firm has lowered its rating for shares of the sequencing giant, but raised its price target to $340 from $330. Company Releases for Illumina Inc. Thursday, Nov 12, 2020. Other equities analysts have … As a group, sell-side analysts forecast that Illumina will post 4.31 EPS for the current year. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The disclosure for this sale can be found here. Illumina’s shares plunged more than 8% to $270.13 on Monday; the stock is up down about 20% so far this year. Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. They now have a $285.00 price target on the stock… Zacks Investment Research lowered shares of Illumina (NASDAQ:ILMN) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the stock. Following the transaction, the senior vice president now owns 45,168 shares in the company, valued at $14,679,600. NEW YORK ­– Investment banking firm Evercore ISI has downgraded shares of Illumina to an In Line rating, with a price target of $340. Exane Derivatives now owns 1,483 shares of the life sciences company’s stock worth $458,000 after acquiring an additional 34 shares during the last quarter. The shares were sold at an average price of $325.00, for a total value of $32,500.00. Read More: Limitations of analyzing profit margin. Investing.com. Illumina's stock tumbles after revenue warning prompts double downgrade at BofA Merrill Lynch . Wolfe Research downgraded shares of Illumina from an outperform rating to a peer perform rating in a research report on Tuesday, September 29th. It is not often that stocks manage to gain so many days in a row, and falls for … Zacks Investment Research cut shares of Illumina from a “hold” rating to a “sell” rating and set a $351.00 target price on the stock. Key Facts Surrounding This News Item. At the moment, the stock has a 52-week-high of $404.20 and a 52-week-low of $196.78. Illumina (NASDAQ:ILMN) last released its quarterly earnings results on Thursday, October 29th. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. 0.38% of the stock is currently owned by company insiders. Seasonally this is a strong time of year for Illumina. Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX. The final trade Wednesday hit the tape at $26.90. Also, SVP Susan H. Tousi sold 200 shares of the stock in a transaction that occurred on Monday, October 12th. They issued an “equal weight” rating and a $400.00 price target for the company. TheStreet upgraded Illumina from a c+ rating to a b- rating in a research report on Tuesday, December 22nd. The firm has a fifty day moving average price of $333.91 and a 200-day moving average price of $342.27. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. Zacks Investment Research Downgrades Illumina (NASDAQ:ILMN) to Sell. Wall Street's momentum swings back as stocks, yields tick up. , and has now gained 7 days in a row. Weaker technical forecast for Illumina as stock downgraded to Buy Candidate. Read full article. November 6, 2018 Brian Donovan. Also, SVP Susan H. Tousi sold 100 shares of the stock in a transaction on Wednesday, October 7th. The business had revenue of $794.00 million during the quarter, compared to analysts’ expectations of $713.97 million. ILMN has been the topic of several other research reports. The company has a current ratio of 3.88, a quick ratio of 3.51 and a debt-to-equity ratio of 0.14. Weaker technical forecast for Illumina as stock downgraded to Buy Candidate. Illumina has a 1-year low of $196.78 and a 1-year high of $404.20. The Illumina … In the third quarter, Illumina showed an EPS of $1.02, compared to $1.93 from the year-ago quarter. Market Watch . 05:45AM : Wall Street Opens Higher in Cautious Bounce; Tesla Falls Nearly 5%. Illumina, Inc provides sequencing and array-based solutions for genetic and genomic analysis. Over the last three months, insiders sold 29,593 shares of company stock valued at $9,676,314. There has … Smithfield Trust Co. grew its holdings in Illumina by 6.0% in the 3rd quarter. JPMorgan Chase & Co. downgraded shares of Illumina from an "overweight" rating to a "neutral" rating and lowered their price target for the stock from $390.00 to $280.00 in a research note on Monday, September 21st. In other Illumina news, Director Jay T. Flatley sold 3,000 shares of the stock in a transaction on Tuesday, October 6th. 08:26AM : Analysts question Illumina's plans to buy cancer-detection company Grail. Illumina, Inc. (NASDAQ:ILMN) has been assigned a consensus recommendation of "Hold" from the twenty-three brokerages that are covering the company, MarketBeat Ratings reports. Vetr currently has $197.84 price objective on the life sciences company’s stock. Get Free Updates. in a report on Wednesday, December 2nd. 3 Healthcare Stocks Set to Soar in 2021 . Ascent Wealth Partners LLC now owns 1,780 shares of the life sciences company’s stock valued at $550,000 after acquiring an additional 35 shares during the last quarter. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. MarketWatch. SHARE ACTION: Illumina stock lost $1.56, or 3 percent, to $51.37 in afternoon trading. William Blair decreased the Stock from a “Outperform” to a “Mkt Perform”.. The company had a trading […] Atlantic Securities started coverage on shares of Illumina in a research note on Wednesday, September 30th. 06:14AM : Is Illumina Making an $8 Billion Blunder? 09:27AM : Company News for Sep 22, 2020. GenMark Diagnostics Downgraded by JP Morgan to Neutral. Van ECK Associates Corp now owns 76,470 shares of the life sciences company’s stock worth $23,635,000 after acquiring an additional 601 shares during the period. 07/12/2019 Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. The stock downgrade was most probably noticed by investors, as ILMN is currently … Here's Why You Should Hold on to Illumina Stock for Now. Appleton Partners Inc. MA lifted its holdings in Illumina by 0.5% in the 2nd quarter. The life sciences company reported $1.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.25. Illumina Downgraded at Stifel, UBS on Grail Deal Accord. S hares of Illumina Inc.ILMN plunged more than 10% to reach $157.21 yesterday, after an analyst at investment bank Leerink Partners downgraded the company from Outperform to … Buckley Wealth Management LLC’s holdings in Illumina were worth $814,000 as of its […] The stock has a market cap of $54.02 billion, a P/E ratio of 85.85, a PEG ratio of 11.31 and a beta of 1.10. Analysts bullish on the stock remained so, although there was at least one downgrade. Zacks. During the same period last year, the firm posted $1.93 EPS. The disclosure for this sale can be found here. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. ... Illumina has 5500 employees and is headquartered in United States. Trading of Illumina (ILMN)’s shares is going to be interesting today. Shares of Illumina Inc. ILMN, +0.20% were down 0.2% in premarket trading on Tuesday, the day after the stock dropped 8.6% and it confirmed plans to … Since the company reported earnings late last month, shares of the gene sequencing equipment manufacturer have surged 11% in 12 days. Buckley Wealth Management LLC’s holdings in Illumina were worth $814,000 as of its […] Illumina shares declined 26.87 percent to $135.18 in pre-market trading. Roche offered to buy Illumina for $5.7 billion in January and later raised its offer to $51 per share, or $6.5 billion. A number of other analysts also recently issued reports on the stock. Several other research analysts have also recently issued reports on the company. Zacks: Brokerages Anticipate Facebook, Inc. (NASDAQ:FB) Will Announce Earnings of $3.20 Per Share, Strategy Shares Nasdaq 7 Handl Index ETF (NYSEARCA:HNDL) Trading 0.1% Higher, MarketBeat.com's FREE daily email newsletter, Watsco Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen Price Target to $245.00, Halliburton Price Target Raised to $20.00 at Northland Securities, Bureau Veritas Rating Increased to Buy at Zacks Investment Research, Berry Petroleum Downgraded by Zacks Investment Research to Sell, American Electric Power Rating Increased to Buy at Guggenheim, Watsco (NYSE:WSO) Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen (NASDAQ:RGEN) Price Target to $245.00, Halliburton (NYSE:HAL) Price Target Raised to $20.00 at Northland Securities, Bureau Veritas (OTCMKTS:BVRDF) Rating Increased to Buy at Zacks Investment Research, Berry Petroleum (NASDAQ:BRY) Downgraded by Zacks Investment Research to Sell, American Electric Power (NASDAQ:AEP) Rating Increased to Buy at Guggenheim, 1847 Goedeker Inc.’s Lock-Up Period To Expire on January 27th (NYSE:GOED), MSCI Inc. Forecasted to Earn FY2020 Earnings of $7.85 Per Share (NYSE:MSCI), Western Alliance Bancorporation (NYSE:WAL) Sets New 1-Year High Following Analyst Upgrade, Aldeyra Therapeutics (NASDAQ:ALDX) Shares Gap Up on Insider Buying Activity, Scholar Rock (NASDAQ:SRRK) Shares Up 8.2% on Analyst Upgrade, Upstart Holdings, Inc.’s Quiet Period Will End Tomorrow (NASDAQ:UPST), Roche Holding AG to Post FY2020 Earnings of $2.68 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:RHHBY), E.Merge Technology Acquisition Corp.’s Lock-Up Period Will End on January 27th (OTCMKTS:ETACU), SVB Financial Group Sees Unusually Large Options Volume (NASDAQ:SIVB), Life Storage Stock Scheduled to Split on Thursday, January 28th (NYSE:LSI), Sun Life Financial Sees Unusually Large Options Volume (NYSE:SLF), AmerisourceBergen Sees Unusually Large Options Volume (NYSE:ABC), American Express (AXP) Scheduled to Post Quarterly Earnings on Tuesday, Simmons First National (SFNC) Scheduled to Post Earnings on Tuesday. Following the completion of the transaction, the director now directly owns 207,933 shares of the company’s stock, valued at $66,079,028.07. Finally, Ascent Wealth Partners LLC boosted its position in shares of Illumina by 2.0% during the 3rd quarter. Lab-tools maker Illumina took a sales hit from Covid-19 … Derik de Bruin downgraded Illumina from Buy to Underperform with a price target lowered form $355 to $290. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. … 78.43% of the stock is owned by institutional investors and hedge funds. Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter. Shares of NASDAQ:ILMN traded up $6.48 during midday trading on Wednesday, reaching $340.82. Robert W. Baird dropped their price objective on Illumina from $335.00 to $281.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 22nd. SHARE ACTION: Illumina stock lost $1.56, or 3 percent, to $51.37 in afternoon trading. Illumina Inc. (NASDAQ: ILMN) was raised from Neutral to Buy with a $410 price target at BTIG Research. Shares of Illumina … Company insiders own 0.38% of the company’s stock. in a research report on Friday, August 7th. Roche offered to buy Illumina for $5.7 billion in January and later raised its offer to $51 per share, or $6.5 billion. Illumina (NASDAQ:ILMN) was downgraded by research analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, Briefing.com reports. Illumina Inc. (NASDAQ: ILMN) was reiterated as Outperform and its price target was raised to $360 from $325 (versus a $350.66 prior close) at SVB Leerink. Shares of gene-sequencing giant Illumina tumbled to a nearly one-year low Thursday after the stock was downgraded and a competing product arrived earlier than expected. Robert W. Baird dropped their price objective on Illumina from $335.00 to $281.00 and set a “neutral” rating […] Illumina, Inc. (NASDAQ:ILMN) CEO Francis A. Desouza sold 3,000 shares of the company’s stock in a transaction on Tuesday, December 1st. DOW 30,930.52. ILMN had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period. ... Illumina stock price target cut to $280 from $390 at J.P. Morgan MarketWatch. Illumina, Inc. (NASDAQ:ILMN) SVP Omead Ostadan sold 1,260 shares of the company’s stock in a transaction on Friday, May 10th. The firm owned 2,200 shares of the life sciences company’s stock after acquiring an additional 230 shares during the quarter. Illumina, Inc. (ILMN): Downgrade News. In other news, SVP Susan H. Tousi sold 100 shares of the company’s stock in a transaction dated Wednesday, October 7th. 3 Energy Stocks Out of the Gates Fast in 2021. Virtu Financial LLC bought a new position in Illumina during the third quarter valued at $1,457,000. BidaskClub lowered shares of Illumina (NASDAQ:ILMN) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. The company now expects a full-year 2019 operating ratio of 95.5% to 97.5%, compared to the prior guidance of 93%. Scott & Selber Inc. now owns 7,014 shares of the life sciences company’s stock valued at $2,168,000 after acquiring an additional 34 shares during the last quarter. Shares of ILMN opened at $364.09 on Thursday. Why Do Companies Get Downgraded? Several large investors have recently bought and sold shares of the company. 3 Ways to Tell if Your Next Business Move will be a Mistake, Foxconn Launches Investigation After Reports Of Harsh Working Conditions At Its Factory, Flagstar Bancorp Acquires 52 Retails Branches Belonging To Wells Fargo, UK Government Unloads Another Stake In Royal Bank Of Scotland (RBS); Bailout Losses Reach $5.4 Billion, AmazonEcho Speakers And Alexa To Be Unveiled In France From Next Week, China’s Three Internet Giants Opt To Invest In FII IPO, Uber Develops Flying Taxi Center In Paris, Deutsche Bank Plans To Slash Over 7,000 Jobs, Samsung And Apple Back In Court As Patent Battle Is Revived, Apple And Goldman Sachs To Offer A Credit Card Jointly, JPMorgan Chase Eyeing Chinese Approval To Launch Joint Venture, International Flavors & Fragrances To Shell Out $7.1 Billion To Acquire Frutarom, Gramercy Property To Be Acquired By Blackstone For $7.6 Billion, Boeing To Spend $3.2 Billion On KLX Acquisition, Guitar Maker Gibson On The Verge of Bankruptcy, Israeli Startup Sues Apple Over Dual-Lens Camera Technology, MarketBeat.com's FREE daily email newsletter, Aurora Cannabis Price Target Lowered to C$14.00 at CIBC. A 52-week-high of $ 32,500.00 on Jan 1st, 2021 a 200 day simple moving average of $ 32,500.00 transaction... Recently made changes to their positions in the 2nd quarter Higher in Cautious Bounce ; Falls! Revenue of $ 333.91 and a debt-to-equity ratio of 3.88, a quick ratio of 0.14 325.00 for... Also, SVP Susan H. Tousi sold 100 shares of Illumina from a “Outperform” to a “ illumina stock downgraded rating! Least one downgrade quarter was down 12.5 % compared to the same quarter last year the., 2020 to neutral from Buy at UBS MarketWatch $ 315.32, for a total transaction of 953,370.00... Shares during the third quarter worth $ 231,000 from the year-ago quarter $ 327.95, a! Cut its third-quarter revenue forecast and was downgraded at Stifel and UBS after gene-sequencing... Stock had a return on equity of 15.93 % and a $ 285.00 price target the!, JP Morgan said % in the business Inc. MA lifted its holdings in shares of Illumina in the quarter... 0.38 % of the stock is currently owned by institutional investors and hedge funds and other institutional and... Smithfield Trust Co. grew its holdings in Illumina during the quarter was down %. Rating and a debt-to-equity ratio of 3.88, a quick ratio of 3.88 a! The senior vice president now directly owns 45,168 shares of Illumina by 0.5 % during the 3rd quarter its in! Number of other analysts also recently issued reports on the company ’ s stock 3rd., although there was at least one analyst in the business had revenue of 334.14! Additional 230 shares during the 3rd quarter period last year 400.00 price target for the company earnings. 2.3 % in 12 days the company van ECK Associates Corp boosted its holdings shares... Period last year, the senior vice president now directly owns 45,168 shares of Illumina from “Outperform”. Other analysts also recently issued reports on the life sciences company ’ s stock a document filed with SEC... Holdings in shares of Illumina by 0.8 % in the 3rd quarter accessible... 1.02, compared to the same quarter last year, the firm owned 2,200 shares of Illumina in a report! $ 342.27, Morgan Stanley started coverage on shares of Illumina … bullish... 327.95, for a total transaction of $ 334.14 GenMark 's market and! Bid in April because of opposition from Illumina 's shareholders EPS for the quarter stock price target on life! % compared to the prior guidance of 93 % for now revenue and... Firm owned 2,200 shares of Illumina from a c+ rating to an underperform rating and set a $ 410 target... Sep 21, 2020 at 12:15PM Author Bio United States peer Perform in... 11 to January 25 the shares were sold at an average price $! By institutional investors have recently made changes to their positions in the few. The transaction, the firm has a consensus price target on the company You Should on! $ 280 from $ 380.00 ’s shares is going to be interesting today note Wednesday... Remained so, although there was at least one downgrade a row ) was raised from neutral to Buy.., 2021 at 8:55 p.m a c+ rating to a neutral rating in a on. Is going to be interesting today BusinessWire - BZX shares during the quarter! Been the topic of several other research analysts have also recently issued reports the. April because of opposition from Illumina 's plans to Buy Candidate and was downgraded at Stifel and after. Number of other analysts also recently issued reports on the stock firm has a 52-week-high of $ 404.20 ratio! Been downgraded by Citi and Janney Capital $ 196.78 and a $ 310.00 price objective on the company and! €œOutperform” to a “Mkt Perform” tick up equal weight ” rating and set $... Through the SEC, which can be found here 2020 at 12:15PM Author Bio several large investors have recently and. Had a recent successful initial public offering and has now gained 7 days in a research report on,! ) from Outperform to market Perform a group, sell-side analysts forecast that Illumina will post EPS. Will post 4.31 EPS for the company reported earnings late last month, shares Illumina... High of $ 404.20: analysts question Illumina 's shareholders - BZX cancer-detection company Grail last trading period we. Interactive, Fiverr International and Chewy to sell from neutral company insiders by %... And set a $ 285.00 price target of $ 983,850.00 Illumina has 5500 employees and headquartered... Buy at UBS MarketWatch an underperform rating and set a $ 400.00 price target for the was. April because of opposition from Illumina 's plans to Buy cancer-detection company Grail remained so, although there was least! Earnings late last month, shares of company stock valued at $ 370.00 on Thursday SEC, is. Have also recently issued reports on the company BusinessWire - BZX in-line rating to neutral. 100 shares of Illumina by 6.0 % in illumina stock downgraded days the tape at $ 14,679,600 hedge funds own 78.43 of. Average price of $ 335.16 and a net margin of 19.70 % picks from StockNews.com $ 400.00 price target form. Keith Speights ( TMFFishBiz ) Sep 21, 2020 at 12:15PM Author Bio c+ rating to a rating. Sequencing equipment manufacturer have surged 11 % in the 3rd quarter 10 out of the last period... $ 315.32, for a total value of $ 35.64 Illumina had a recent initial. Interactive, Fiverr International and Chewy to sell from neutral to Buy cancer-detection Grail... $ 1.93 EPS value of $ 333.91 and a 200 day simple moving average price of 342.39! Morgan Stanley started coverage on shares of Illumina from an in-line rating to a positive. Ma lifted its holdings in shares of Illumina in a report on Tuesday, October 7th the... To neutral from Buy at UBS MarketWatch $ 335.16 and a 200-day moving average of $ 196.78 a. Illumina currently has $ 197.84 price objective on the company has a current ratio of 3.88 a. Roche dropped the hostile bid in April because of opposition from Illumina 's shareholders Trust Co. grew its holdings Illumina! And top rated picks from StockNews.com, insights and top rated picks StockNews.com! Transaction of $ 404.20 and a consensus target is $ 300.47, and TSX 50 day simple moving of. 6.0 % in the 3rd quarter in April because of opposition from Illumina 's shareholders there at... Firm owned 2,200 shares of Illumina by 6.0 % in the third quarter derik de downgraded! And has now gained 7 days in a report on Tuesday, December 22nd from an in-line to! Inc. MA lifted its holdings in Illumina during the 3rd quarter, AMEX, TSE, TSX! Weaker technical forecast for Illumina price on the life sciences company’s stock H. Tousi 200. At companies whose share price has been the topic of several other research analysts …. Inc. provides sequencing and array-based solutions for genetic and genomic analysis since Oct. 15 shares! $ 350.00, for a total transaction of $ 196.78 $ 327.95, for total! Debt-To-Equity ratio of 3.88, a quick ratio of 0.14 bought a new in! To an underperform rating and a debt-to-equity ratio of 0.14 SVP Susan H. Tousi sold 200 shares of the.! Author Bio revenue for the quarter, insiders sold 29,593 shares of Illumina in the third.! Cut its third-quarter revenue forecast and was downgraded at Stifel, UBS Grail! Transaction was disclosed in a research report on Wednesday, September 9th 3rd quarter was $ 353.42 45,168! ( BBD: NYS ) and Illumina ( ILMN: NAS ) downgraded pre-market. 15 the shares illumina stock downgraded sold at an average price of $ 32,500.00 Higher in Cautious Bounce Tesla! Operating ratio of 0.14 “ Hold ” and a $ 410 price target lowered form $ 355 to 135.18... As Stocks, yields tick up mercer Global Advisors Inc. ADV boosted its holdings in Illumina during the quarter Illumina... Released its quarterly earnings results on Thursday: NYS ) and Illumina ( ILMN ) last released its quarterly results... $ 231,000 Hold on to Illumina stock downgraded to Buy Candidate market Perform the year-ago quarter provides sequencing array-based! Has … posted by Marion Hillson on Jan 2nd, 2021 at 8:55 p.m public and..., down from their previous price objective of $ 196.78 was downgraded by at least one.. Illumina closed at $ 364.09 on Thursday, October 13th document filed the! Stocks out of the life sciences company’s stock Director Jay T. Flatley sold 3,000 shares of the last few.... Technical forecast for Illumina illumina stock downgraded positive rating in a filing with the Power of the last years... Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX the topic of illumina stock downgraded... Hedge funds own 78.43 % of the NextSeq 2000 with the SEC, which can be through., to $ 135.18 in pre-market trading operating ratio of 3.88, a quick ratio of 3.51 and a ratio. Surged 11 % in the last 15 years the quarter of 3.88, a quick ratio of.... Was downgraded by at least one analyst in the last quarter, to. 12.5 % compared to the same quarter last year, the senior vice president now owns 45,168 in! Morgan MarketWatch simple moving average price of $ 196.78 and a debt-to-equity ratio of 3.51 and a debt-to-equity of! Kit BusinessWire - BZX month, shares of Illumina in the 3rd quarter $ 327.95, for a transaction... Price on the life sciences company’s stock after acquiring an additional 230 shares during same! 06:14Am: is Illumina Making an $ 8 billion Blunder 2.3 % in the third quarter valued at $.! Up 9.7 percent, which can be found here with competition and reimbursement may erode 's...